RxDoctor Payments Data

Eugen Campian

Obstetrics & Gynecology · Red Wing, MNNPI 1740319003

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $124,125 of the $137,491 with a category attached, or 90.3%. AbbVie accounts for 93.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $71,778 and has fallen 99.6% since, to $323 in 2024. Among obstetrics & gynecology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$137,491in general payments, 2019–2025

Across 179 payments — averaging $768.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$129K
  • Teleflex LLC$3K
  • Duchesnay USA Incorporated$2K
  • Coloplast$1K
  • Axonics, Inc.$641
  • Boston Scientific$445
  • plus $1K from 6 others
$2,100in research payments, 2019–2025

Across 1 payment — averaging $2100.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$2K

What the payments were for

  • Consulting fees$2,9932%
  • Speaking & faculty fees$124,12590%
  • Travel & lodging$5,2664%
  • Food & beverage$5,0504%
  • Education$570%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$137,491 in reported general payments places this provider in the 95th percentile of 615 obstetrics & gynecology providers in Minnesota.

See all obstetrics & gynecology providers in Minnesota

Medicare billing

Part B allowed, 2024
$26,869
Medicare patients
72
Services billed
305

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol48$3,090
Trospium Chloride50$1,983
Estradiol (Once Weekly)Estradiol14$674
Methenamine Hippurate19$650
Solifenacin Succinate19$591
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst29$313
Oxycodone Hcl24$109

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Red Wing

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →